Label: MOTION SICKNESS- meclizine hcl tablet, chewable

  • NDC Code(s): 70677-1290-1
  • Packager: Strategic Sourcing Services LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated May 21, 2025

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each chewable tablet)

    Meclizine HCl 25 mg

  • Purpose

    Antiemetic

  • Uses

    for prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness

  • Warnings

    Do not use

    for children under 12 years of age unless directed by a doctor.

    Ask a doctor before use if you have

    • glaucoma
    • difficulty in urination due to enlargement of the prostate gland
    • a breathing problem such as emphysema or chronic bronchitis

    Ask a doctor or pharmacist before use if you are

    taking sedatives or tranquilizers.

    When using this product

    • drowsiness may occur
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • avoid alcoholic beverages
    • use caution when driving a motor vehicle or operating machinery

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • do not take more than directed
    • dosage should be taken one hour before travel starts
    • chew or crush tablets completely before swallowing; do not swallow tablets whole
    • adults and children 12 years and over: take 1 to 2 chewable tablets once daily or as directed by a doctor
  • Other information

    • TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN
    • store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
    • protect from heat and humidity
    • see end flap for expiration date and lot number 
  • Inactive ingredients

    colloidal silicon dioxide, dextrose, FD&C red #40 aluminum lake, flavor, lactose monohydrate, magnesium stearate, pregelatinized starch, propylene glycol, saccharin sodium, silicon dioxide

  • Questions or comments?

    1-800-426-9391

  • Principal Display Panel

    NDC 70677-1290-1

    *COMPARE TO THE ACTIVE INGREDIENT IN
    BONINE® CHEWABLE TABLETS

    Foster & Thrive 

    Motion Sickness
    Meclizine HCl 25 mg Chewable Tablets

    ANTIEMETIC

    Helps Prevent Nausea,
    Vomiting and Dizziness
    due to Motion Sickness for
    up to 24 Hours
    Ages 12 Years and Over

    Chew or crush tablets
    completely before swallowing.

    100 CHEWABLE TABLETS

    RASPBERRY
    FLAVOR

    TAMPER EVIDENT: DO NOT USE IF
    IMPRINTED SAFETY SEAL UNDER CAP
    IS BROKEN OR MISSING

    *This product is not manufactured or distributed by
    WellSpring Pharmaceutical Corporation, owner of the
    registered trademark Bonine® Chewable Tablets.

    50844 ORG082340412 Rev. 02/25

    ©2023 McKesson Corporation

    Distributed by: McKesson Corp., via SSSL,
    Memphis, TN 38141
    Money Back Guarantee
    www.fosterandthrive.com

    Foster and thrive 44-404A

    Foster and thrive 44-404A

     

  • INGREDIENTS AND APPEARANCE
    MOTION SICKNESS 
    meclizine hcl tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70677-1290
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
    FD&C RED NO. 40 ALUMINUM LAKE (UNII: 6T47AS764T)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
    Product Characteristics
    ColorpinkScoreno score
    ShapeROUNDSize9mm
    FlavorRASPBERRYImprint Code 44;404
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70677-1290-1100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product05/30/2025
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00905/30/2025
    Labeler - Strategic Sourcing Services LLC (116956644)
    Establishment
    NameAddressID/FEIBusiness Operations
    LNK International, Inc.832867837manufacture(70677-1290) , pack(70677-1290)
    Establishment
    NameAddressID/FEIBusiness Operations
    LNK International, Inc.117025878manufacture(70677-1290)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!